Patient-reported outcomes (PROs) in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the phase II GEOMETRY mono-1 study

J. Wolf; E. B. Garon; H. J. M. Groen; D. S. -W Tan; null Gilloteau; S. Le Mouhaer; C. Cai; A. Chassot-Agostinho; M. Reynolds; D. Odom; R. S. Heist

Patient-reported outcomes (PROs) in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the phase II GEOMETRY mono-1 study

J. Wolf, E. B. Garon, H. J. M. Groen, D. S. -W Tan, Gilloteau, S. Le Mouhaer, C. Cai, A. Chassot-Agostinho, M. Reynolds, D. Odom, R. S. Heist

Onderzoeksoutput › Academic

Originele taal-2	English
Pagina's (van-tot)	110-110
Aantal pagina's	1
Tijdschrift	Oncology Research and Treatment
Volume	44
Status	Published - sep.-2021

Handle.net

Permanente koppeling

Citeer dit

@article{75ef633ccc694872b44c5ea1ef348542,

title = "Patient-reported outcomes (PROs) in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the phase II GEOMETRY mono-1 study",

author = "J. Wolf and Garon, {E. B.} and Groen, {H. J. M.} and Tan, {D. S. -W} and Gilloteau and {Le Mouhaer}, S. and C. Cai and A. Chassot-Agostinho and M. Reynolds and D. Odom and Heist, {R. S.}",

year = "2021",

month = sep,

language = "English",

volume = "44",

pages = "110--110",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "KARGER",

}

TY - JOUR

T1 - Patient-reported outcomes (PROs) in capmatinib-treated patients with METex14-mutated advanced NSCLC

T2 - Results from the phase II GEOMETRY mono-1 study

AU - Wolf, J.

AU - Garon, E. B.

AU - Groen, H. J. M.

AU - Tan, D. S. -W

AU - Gilloteau, null

AU - Le Mouhaer, S.

AU - Cai, C.

AU - Chassot-Agostinho, A.

AU - Reynolds, M.

AU - Odom, D.

AU - Heist, R. S.

PY - 2021/9

Y1 - 2021/9

M3 - Meeting Abstract

VL - 44

SP - 110

EP - 110

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

SN - 2296-5270

ER -